v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2024
Apr. 30, 2023
Operating activities    
Net income $ 46,264 $ 499
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 42,689 26,409
Amortization of intangible assets 5,995 4,174
Amortization of deferred contract acquisition costs 74,128 55,322
Non-cash operating lease cost 3,372 3,092
Stock-based compensation expense 183,125 130,856
Deferred income taxes (255) (255)
Realized gains on strategic investments (6,881) 0
Non-cash interest expense 874 754
Accretion of short-term investments purchased at a discount 2,285 0
Changes in operating assets and liabilities, net of impact of acquisitions    
Accounts receivable, net 150,249 165,089
Deferred contract acquisition costs (66,480) (49,532)
Prepaid expenses and other assets (28,602) (8,542)
Accounts payable 276 (18,596)
Accrued expenses and other liabilities (16,629) (36,576)
Accrued payroll and benefits (17,692) (17,281)
Operating lease liabilities (4,531) (3,199)
Deferred revenue 15,041 48,678
Net cash provided by operating activities 383,228 300,892
Investing activities    
Purchases of property and equipment (49,683) (62,264)
Capitalized internal-use software and website development costs (10,479) (10,902)
Purchases of strategic investments (1,658) (10,513)
Proceeds from sales of strategic investments 10,407 0
Business acquisitions, net of cash acquired (96,376) 0
Proceeds from maturities and sales of short-term investments 97,300 150,000
Purchases of deferred compensation investments (609) (290)
Net cash (used in) provided by investing activities (51,098) 66,031
Financing activities    
Proceeds from the issuance of common stock upon exercise stock options 823 2,651
Distributions to non-controlling interest holders (3,841) 0
Capital contributions from non-controlling interest holders 500 5,257
Net cash (used in) provided by financing activities (2,518) 7,908
Effect of foreign exchange rates on cash, cash equivalents and restricted cash (1,917) (190)
Net increase in cash, cash equivalents and restricted cash 327,695 374,641
Cash, cash equivalents and restricted cash at beginning of period 3,377,597 2,456,924
Cash, cash equivalents and restricted cash at end of period 3,705,292 2,831,565
Cash and cash equivalents 3,702,437 2,829,677
Restricted cash included in prepaid expenses and other assets 2,855 1,888
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 3,705,292 2,831,565
Supplemental disclosure of cash flow information:    
Interest paid 11,250 11,250
Income taxes paid, net of refunds received 7,594 3,377
Supplemental disclosure of non-cash investing and financing activities:    
Net decrease in property and equipment included in accounts payable and accrued expenses (17,655) (22,479)
Equity consideration for acquisitions 468 0
Operating lease liabilities arising from obtaining operating right-of-use assets 1,759 13,847
Purchases of intangible assets included in accrued expenses and other liabilities 0 500
Proceeds from sales of strategic investments not yet received 4,734 0
Stock-based compensation included in capitalized software development costs and fixed assets 7,966 6,502
Noncash consideration for the purchase of strategic investments 3,319 0
Noncash consideration received from sales of strategic investments $ 3,319 $ 0